Treatment of CD271low melanoma cell lines with TGFβ1 at different time points led to an increase in CD271 expression at both messenger RNA (mRNA) and protein levels in different cell lines (Fig. 2d, e and Supplementary Fig. 1b). This evidence concerns the gene NGFR and melanoma.